Skip to main content
SpringerLink
Log in
Book cover

Endocrine Pathology: pp 429–445Cite as

Endocrine Lung

  • Chapter
  • First Online:

  • 2239 Accesses

Abstract

Neuroendocrine lesions of the lung include neuroendocrine cell hyperplasia and tumorlets, and a spectrum of pulmonary neuroendocrine tumors that includes the low-grade typical carcinoid (TC), intermediate-grade atypical carcinoid (AC), and the high-grade tumors of large cell neuroendocrine carcinoma (LCNEC) and small cell carcinoma (SCLC). Diffuse idiopathic neuroendocrine cell hyperplasia is a very rare condition that represents a pre-invasive lesion for carcinoid tumors. Despite the common neuroendocrine properties of TC, AC, LCNEC, and SCLC, there are major clinical, epidemiologic, and genetic differences between carcinoid tumors and the high-grade SCLC and LCNEC. Both TC and AC can occur in patients with Multiple Endocrine Neoplasia (MEN) type I but LCNEC and SCLC do not. In contrast to LCNEC or SCLC, both TC and AC can have associated neuroendocrine cell hyperplasia with or without tumorlets. Also, both LCNEC and SCLC can demonstrate histologic heterogeneity with other major histologic types of lung carcinoma, such as adenocarcinoma or squamous cell carcinoma, but is not characteristic of TC or AC. The diagnosis of SCLC, TC, and AC can be made by light microscopy without the need for special tests in most cases, but for LCNEC it is required to demonstrate neuroendocrine differentiation by immunohistochemistry or electron microscopy. Finally, genetic changes are very high in SCLC and LCNEC, but usually low for TC and intermediate for AC.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Gosney JR (1992) Pulmonary endocrine pathology. Butterworth-Heinemann, Oxford, Boston

    Google Scholar 

  2. Thunnissen FB, Van Eijk J, Baak JP et al (1988) Bronchopulmonary carcinoids and regional lymph node metastases. A quantitative pathologic investigation. Am J Pathol 132:119–122

    CAS  PubMed  Google Scholar 

  3. Jones DJ, Hasleton PS, Moore M (1988) DNA ploidy in bronchopulmonary carcinoid tumours. Thorax 43:195–199

    CAS  PubMed  Google Scholar 

  4. Rusch VW, Klimstra DS, Venkatraman ES (1996) Molecular markers help characterize neuroendocrine lung tumors. Ann Thorac Surg 62(3):798–809

    CAS  PubMed  Google Scholar 

  5. Brambilla E, Negoescu A, Gazzeri S et al (1996) Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors. Am J Pathol 149(6):1941–1952

    CAS  PubMed  Google Scholar 

  6. Travis WD, Linnoila RI, Tsokos MG et al (1991) Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 15:529–553

    CAS  PubMed  Google Scholar 

  7. Travis WD, Krug LM, Rusch V (2006) Large cell neuroendocrine carcinoma. In: Raghavan D, Brecher ML, Johnson DH, Meropol NJ, Moots PL, Rose PG et al (eds) Textbook of uncommon cancer. Wiley, Chichester, West Sussex, England, pp 298–306

    Google Scholar 

  8. Travis WD (2006) Neuroendocrine lung tumors. Pathol Case Reviews 11(6):235–242

    Google Scholar 

  9. Chaussade L, Eymin B, Brambilla E, Gazzeri S (2001) Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status. Oncogene 20(45):6587–6596

    CAS  PubMed  Google Scholar 

  10. Dosaka-Akita H, Cagle PT, Hiroumi H et al (2000) Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung. Cancer 88(3):550–556

    CAS  PubMed  Google Scholar 

  11. Onuki N, Wistuba II, Travis WD et al (1999) Genetic changes in the spectrum of neuroendocrine lung tumors. Cancer 85(3):600–607

    CAS  PubMed  Google Scholar 

  12. Sampietro G, Tomasic G, Collini P et al (2000) Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis. Appl Immunohistochem Mol Morphol 8(1):49–56

    CAS  PubMed  Google Scholar 

  13. Shin JH, Kang SM, Kim YS et al (2005) Identification of tumor suppressor loci on the long arm of chromosome 5 in pulmonary large cell neuroendocrine carcinoma. Chest 128(4):2999–3003

    CAS  PubMed  Google Scholar 

  14. Travis WD, Travis LB, Devesa SS (1995) Lung cancer [published erratum appears in Cancer 1995 Jun 15; 75(12):2979]. Cancer 75:191–202

    CAS  PubMed  Google Scholar 

  15. Chen LC, Travis WD, Krug LM (2006) Pulmonary neuroendocrine tumors: what (little) do we know? J Natl Compr Canc Netw 4(6):623–630

    PubMed  Google Scholar 

  16. Arrigoni MG, Woolner LB, Bernatz PE (1972) Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 64:413–421

    CAS  PubMed  Google Scholar 

  17. Capella C, Heitz PU, Hofler H, Solcia E, Kloppel G (1995) Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch 425:547–560

    CAS  PubMed  Google Scholar 

  18. Warren WH, Faber LP, Gould VE (1989) Neuroendocrine neoplasms of the lung. A clinicopathologic update. J Thorac Cardiovasc Surg 98:321–332

    CAS  PubMed  Google Scholar 

  19. Moran CA, Suster S, Coppola D, Wick MR (2009) Neuroendocrine carcinomas of the lung: a critical analysis. Am J Clin Pathol 131(2):206–221

    PubMed  Google Scholar 

  20. Lauweryns JM, Goddeeris P (1975) Neuroepithelial bodies in the human child and adult lung. Am Rev Respir Dis 111:469–476

    CAS  PubMed  Google Scholar 

  21. Gosney J, Heath D, Williams D et al (1988) Pulmonary endocrine cells in various species in the Himalaya. J Comp Pathol 99(1):93–100

    CAS  PubMed  Google Scholar 

  22. Aguayo SM, Miller YE, Waldron JA Jr et al (1992) Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med 327:1285–1288

    CAS  PubMed  Google Scholar 

  23. Gosney JR (2004) Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia as a precursor to pulmonary neuroendocrine tumors. Chest 125(5 Suppl):108S

    PubMed  Google Scholar 

  24. Miller RR, Muller NL (1995) Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumors. Am J Surg Pathol 19:653–658

    CAS  PubMed  Google Scholar 

  25. Lauweryns JM, Peuskens JC (1972) Neuro-epithelial bodies (neuroreceptor or secretory organs?) in human infant bronchial and bronchiolar epithelium. Anat Rec 172:471–481

    CAS  PubMed  Google Scholar 

  26. Stahlman MT, Jones M, Gray ME, Kasselberg AG, Vaughn WK (1987) Ontogeny of neuroendocrine cells in human fetal lung. III. An electron microscopic immunohistochemical study. Lab Invest 56:629–641

    CAS  PubMed  Google Scholar 

  27. Johnson MD, Gray ME, Stahlman MT (1988) Calcitonin gene-related peptide in human fetal lung and in neonatal lung disease. J Histochem Cytochem 36:199–204

    CAS  PubMed  Google Scholar 

  28. Emanuel RL, Torday JS, Mu Q, Asokananthan N, Sikorski KA, Sunday ME (1999) Bombesin-like peptides and receptors in normal fetal baboon lung: roles in lung growth and maturation. Am J Physiol 277(5 Pt 1):L1003–L1017

    CAS  PubMed  Google Scholar 

  29. Sunday ME, Yoder BA, Cuttitta F, Haley KJ, Emanuel RL (1998) Bombesin-like peptide mediates lung injury in a baboon model of bronchopulmonary dysplasia. J Clin Invest 102(3):584–594

    CAS  PubMed  Google Scholar 

  30. Pan J, Luk C, Kent G, Cutz E, Yeger H (2006) Pulmonary neuroendocrine cells, airway innervation, and smooth muscle are altered in Cftr null mice. Am J Respir Cell Mol Biol 35(3):320–326

    CAS  PubMed  Google Scholar 

  31. Cutz E, Fu XW, Yeger H (2004) Methods to study neuroepithelial bodies as airway oxygen sensors. Methods Enzymol 381:26–40

    CAS  PubMed  Google Scholar 

  32. Fu XW, Nurse CA, Cutz E (2004) Expression of functional purinergic receptors in pulmonary neuroepithelial bodies and their role in hypoxia chemotransmission. Biol Chem 385(3–4):275–284

    CAS  PubMed  Google Scholar 

  33. Pan J, Yeger H, Cutz E (2004) Innervation of pulmonary neuroendocrine cells and neuroepithelial bodies in developing rabbit lung. J Histochem Cytochem 52(3):379–389

    CAS  PubMed  Google Scholar 

  34. Cutz E, Fu XW, Nurse CA (2003) Ionotropic receptors in pulmonary neuroepithelial bodies (NEB) and their possible role in modulation of hypoxia signalling. Adv Exp Med Biol 536:155–161

    CAS  PubMed  Google Scholar 

  35. Pan J, Copland I, Post M, Yeger H, Cutz E (2006) Mechanical stretch-induced serotonin release from pulmonary neuroendocrine cells: implications for lung development. Am J Physiol Lung Cell Mol Physiol 290(1):L185–L193

    CAS  PubMed  Google Scholar 

  36. Cunningham GJ, Nassau E, Walter JB (1958) The frequency of tumor-like formations in bronchiectatic lungs. Thorax 13:64–68

    CAS  PubMed  Google Scholar 

  37. Rodgers-Sullivan RF, Weiland LH, Palumbo PJ, Hepper NGG (1978) Pulmonary tumorlets associated with Cushing’s syndrome. Am Rev Respir Dis 117:799–806

    CAS  PubMed  Google Scholar 

  38. Whitwell F (1955) Tumourlets of the lung. J Pathol Bacteriol 70:529–541

    CAS  PubMed  Google Scholar 

  39. Marchevsky A, Nieburgs HE, Olenko E, Kirschner P, Teirstein A, Kleinerman J (1982) Pulmonary tumorlets in cases of “tuberculoma” of the lung with malignant cells in brush biopsy. Acta Cytol 26:491–494

    CAS  PubMed  Google Scholar 

  40. Pelosi G, Zancanaro C, Sbabo L, Bresaola E, Martignoni G, Bontempini L (1992) Development of innumerable neuroendocrine tumorlets in pulmonary lobe scarred by intralobar sequestration. Immunohistochemical and ultrastructural study of an unusual case. Arch Pathol Lab Med 116:1167–1174

    CAS  PubMed  Google Scholar 

  41. Ranchod M (1977) The histogenesis and development of pulmonary tumorlets. Cancer 39:1135–1145

    CAS  PubMed  Google Scholar 

  42. Canessa PA, Santini D, Zanelli M, Capecchi V (1997) Pulmonary tumourlets and microcarcinoids in bronchiectasis. Monaldi Arch Chest Dis 52(2):138–139

    CAS  PubMed  Google Scholar 

  43. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E, in collaboration with L.H.Sobin and pathologists from 14 Countries (1999) Histological typing of lung and pleural tumors, 3rd edn. Springer, Berlin

    Google Scholar 

  44. Brown MJ, English J, Muller NL (1997) Bronchiolitis obliterans due to neuroendocrine hyperplasia: high-resolution CT–pathologic correlation. AJR Am J Roentgenol 168(6):1561–1562

    CAS  PubMed  Google Scholar 

  45. Sheerin N, Harrison NK, Sheppard MN, Hansell DM, Yacoub M, Clark TJ (1995) Obliterative bronchiolitis caused by multiple tumourlets and microcarcinoids successfully treated by single lung transplantation. Thorax 50:207–209

    CAS  PubMed  Google Scholar 

  46. Davies SJ, Gosney JR, Hansell DM et al (2007) Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax 62(3):248–252

    PubMed  Google Scholar 

  47. Asamura H, Kameya T, Matsuno Y et al (2006) Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 24(1):70–76

    PubMed  Google Scholar 

  48. Filosso PL, Rena O, Donati G et al (2002) Bronchial carcinoid tumors: surgical management and long-term outcome. J Thorac Cardiovasc Surg 123(2):303–309

    PubMed  Google Scholar 

  49. McCaughan BC, Martini N, Bains MS (1985) Bronchial carcinoids. Review of 124 cases. J Thorac Cardiovasc Surg 89:8–17

    CAS  PubMed  Google Scholar 

  50. Mezzetti M, Raveglia F, Panigalli T et al (2003) Assessment of outcomes in typical and atypical carcinoids according to latest WHO classification. Ann Thorac Surg 76(6):1838–1842

    PubMed  Google Scholar 

  51. Schrevens L, Vansteenkiste J, Deneffe G et al (2004) Clinical-radiological presentation and outcome of surgically treated pulmonary carcinoid tumours: a long-term single institution experience. Lung Cancer 43(1):39–45

    PubMed  Google Scholar 

  52. Cardillo G, Sera F, Di MM et al (2004) Bronchial carcinoid tumors: nodal status and long-term survival after resection. Ann Thorac Surg 77(5):1781–1785

    PubMed  Google Scholar 

  53. Bonikos DS, Bensch KG, Jamplis RW (1976) Peripheral pulmonary carcinoid tumors. Cancer 37:1977–1998

    CAS  PubMed  Google Scholar 

  54. Francia G, Davi MV, Montresor E, Colato C, Ferdeghini M, Lo Cascio V (2006) Long-term quiescence of ectopic Cushing’s syndrome caused by pulmonary neuroendocrine tumor (typical carcinoid) and tumorlets: spontaneous remission or therapeutic effect of bromocriptine? J Endocrinol Invest 29(4):358–362

    CAS  PubMed  Google Scholar 

  55. Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK (2005) Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J Clin Endocrinol Metab 90(8):4955–4962

    CAS  PubMed  Google Scholar 

  56. Bhansali A, Rana SS, Bhattacharya S, Muralidharan R, Dash RJ, Banerjee AK (2002) Acromegaly: a rare manifestation of bronchial carcinoid. Asian Cardiovasc Thorac Ann 10(3):273–274

    PubMed  Google Scholar 

  57. Sachithanandan N, Harle RA, Burgess JR (2005) Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1. Cancer 103(3):509–515

    PubMed  Google Scholar 

  58. Ranchod M, Levine GD (1980) Spindle-cell carcinoid tumors of the lung: a clinicopathologic study of 35 cases. Am J Surg Pathol 4:315–331

    CAS  PubMed  Google Scholar 

  59. Iihara K, Yamaguchi K, Fujioka Y, Uno S (2002) Pigmented neuroendocrine tumor of the lung, showing neuromelanin. Pathol Int 52(11):734–739

    PubMed  Google Scholar 

  60. Gal AA, Koss MN, Hochholzer L, DeRose PB, Cohen C (1993) Pigmented pulmonary carcinoid tumor. An immunohistochemical and ultrastructural study. Arch Pathol Lab Med 117:832–836

    CAS  PubMed  Google Scholar 

  61. el-Gatit A, Al-Kaisi N, Moftah S et al (1994) Atypical bronchial carcinoid tumour with amyloid deposition. Eur J Surg Oncol 20:586–587

    CAS  PubMed  Google Scholar 

  62. Abe Y, Utsunomiya H, Tsutsumi Y (1992) Atypical carcinoid tumor of the lung with amyloid stroma. Acta Pathol Jpn 42:286–292

    CAS  PubMed  Google Scholar 

  63. Chong S, Lee KS, Chung MJ, Han J, Kwon OJ, Kim TS (2006) Neuroendocrine tumors of the lung: clinical, pathologic, and imaging findings. Radiographics 26(1):41–57

    PubMed  Google Scholar 

  64. Travis WD, Rush W, Flieder DB et al (1998) Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 22(8):934–944

    CAS  PubMed  Google Scholar 

  65. Gupta R, Dastane A, McKenna RJ Jr, Marchevsky AM (2009) What can we learn from the errors in the frozen section diagnosis of pulmonary carcinoid tumors? An evidence-based approach. Hum Pathol 40(1):1–9

    PubMed  Google Scholar 

  66. Sturm N, Rossi G, Lantuejoul S et al (2002) Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Hum Pathol 33(2):175–182

    PubMed  Google Scholar 

  67. Du EZ, Goldstraw P, Zacharias J et al (2004) TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Hum Pathol 35(7):825–831

    CAS  PubMed  Google Scholar 

  68. Oliveira AM, Tazelaar HD, Myers JL, Erickson LA, Lloyd RV (2001) Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites. Am J Surg Pathol 25(6):815–819

    CAS  PubMed  Google Scholar 

  69. Aslan DL, Gulbahce HE, Pambuccian SE, Manivel JC, Jessurun J (2005) Ki-67 immunoreactivity in the differential diagnosis of pulmonary neuroendocrine neoplasms in specimens with extensive crush artifact. Am J Clin Pathol 123(6):874–878

    CAS  PubMed  Google Scholar 

  70. Iyoda A, Hiroshima K, Moriya Y et al (2004) Pulmonary large cell neuroendocrine carcinoma demonstrates high proliferative activity. Ann Thorac Surg 77(6):1891–1895

    PubMed  Google Scholar 

  71. Pelosi G, Rodriguez J, Viale G, Rosai J (2005) Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients. Am J Surg Pathol 29(2):179–187

    PubMed  Google Scholar 

  72. Stamatis G, Freitag L, Greschuchna D (1990) Limited and radical resection for tracheal and bronchopulmonary carcinoid tumour. Report on 227 cases. Eur J Cardiothorac Surg 4:527–532

    CAS  PubMed  Google Scholar 

  73. Berendsen HH, Postmus PE, Edens ET, Sluiter HJ (1986) Irresectable bronchial carcinoid with a 32-year natural history. A report of two cases treated with Neodymium-YAG-laser, initially misinterpreted as small cell lung cancer. Eur J Respir Dis 68:151–154

    CAS  PubMed  Google Scholar 

  74. Breederveld RS, Meijer S, Thunnissen FB, Stam J (1989) Surgical treatment of bronchopulmonary carcinoid tumours. Neth J Surg 41:82–84

    CAS  PubMed  Google Scholar 

  75. Daddi N, Ferolla P, Urbani M et al (2004) Surgical treatment of neuroendocrine tumors of the lung. Eur J Cardiothorac Surg 26(4):813–817

    PubMed  Google Scholar 

  76. Warren WH, Gould VE (1990) Long-term follow-up of classical bronchial carcinoid tumors. Clinicopathologic observations. Scand J Thorac Cardiovasc Surg 24:125–130

    CAS  PubMed  Google Scholar 

  77. Thomas CF Jr, Tazelaar HD, Jett JR (2001) Typical and atypical pulmonary carcinoids: outcome in patients presenting with regional lymph node involvement. Chest 119(4):1143–1150

    PubMed  Google Scholar 

  78. Beasley MB, Thunnissen FB, Brambilla E et al (2000) Pulmonary atypical carcinoid: predictors of survival in 106 cases. Hum Pathol 31(10):1255–1265

    CAS  PubMed  Google Scholar 

  79. Fink G, Krelbaum T, Yellin A et al (2001) Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest 119(6):1647–1651

    CAS  PubMed  Google Scholar 

  80. Garcia-Yuste M, Matilla JM, Cueto A et al (2007) Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung. Eur J Cardiothorac Surg 31(2):192–197

    PubMed  Google Scholar 

  81. Pelosi G, Scarpa A, Puppa G et al (2005) Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Cancer 103(6):1154–1164

    CAS  PubMed  Google Scholar 

  82. Rea F, Rizzardi G, Zuin A et al (2007) Outcome and surgical strategy in bronchial carcinoid tumors: single institution experience with 252 patients. Eur J Cardiothorac Surg 31(2):186–191

    PubMed  Google Scholar 

  83. Rusch VW, Appelman HD, Byhardt R et al (2002) Lung. In: Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG et al (eds) AJCC cancer staging manual. Springer, New York, pp 167–181

    Google Scholar 

  84. (2003) Lung. In: Wittekind C, Greene FL, Henson DE, Hutter RVP, Sobin LH (eds). UICC International Union Against Cancer, TNM supplement, a commentary on uniform use. Wiley-Liss, New York, pp 47,97,143–49,98,144

    Google Scholar 

  85. (2003) UICC International Union Against Cancer, Explanatory Notes for Anatomic Sites – Lung. In: Wittekind C, Greene FL, Henson DE, Hutter RVP, Sobin LH (eds) UICC International Union Against Cancer, TNM supplement, a commentary on uniform use. Wiley, New York, pp 47–49

    Google Scholar 

  86. (2003) UICC International Union Against Cancer, TNM supplement, a commentary on uniform use, 3rd edn. Wiley, New York

    Google Scholar 

  87. Travis WD, Giroux DJ, Chansky K et al (2008) The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for lung cancer. J Thorac Oncol 3(11):1213–1223

    PubMed  Google Scholar 

  88. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC (2004) Pathology and genetics: tumours of the lung, pleura, thymus and heart. IARC, Lyon

    Google Scholar 

  89. Veronesi G, Morandi U, Alloisio M et al (2006) Large cell neuroendocrine carcinoma of the lung: a retrospective analysis of 144 surgical cases. Lung Cancer 53(1):111–115

    PubMed  Google Scholar 

  90. Battafarano RJ, Fernandez FG, Ritter J et al (2005) Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer. J Thorac Cardiovasc Surg 130(1):166–172

    PubMed  Google Scholar 

  91. Dresler CM, Ritter JH, Patterson GA, Ross E, Bailey MS, Wick MR (1997) Clinical-pathologic analysis of 40 patients with large cell neuroendocrine carcinoma of the lung. Ann Thorac Surg 63(1):180–185

    CAS  PubMed  Google Scholar 

  92. Zacharias J, Nicholson AG, Ladas GP, Goldstraw P (2003) Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic nodal dissection. Ann Thorac Surg 75(2):348–352

    PubMed  Google Scholar 

  93. Iyoda A, Hiroshima K, Baba M, Saitoh Y, Ohwada H, Fujisawa T (2002) Pulmonary large cell carcinomas with neuroendocrine features are high-grade neuroendocrine tumors. Ann Thorac Surg 73(4):1049–1054

    PubMed  Google Scholar 

  94. Garcia-Yuste M, Matilla JM, Alvarez-Gago T et al (2000) Prognostic factors in neuroendocrine lung tumors: a Spanish Multicenter Study. Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR). Ann Thorac Surg 70(1):258–263

    CAS  PubMed  Google Scholar 

  95. Takei H, Asamura H, Maeshima A et al (2002) Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases. J Thorac Cardiovasc Surg 124(2):285–292

    PubMed  Google Scholar 

  96. Oshiro Y, Kusumoto M, Matsuno Y et al (2004) CT findings of surgically resected large cell neuroendocrine carcinoma of the lung in 38 patients. AJR Am J Roentgenol 182(1):87–91

    PubMed  Google Scholar 

  97. Rossi G, Marchioni A, Milani M et al (2004) TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung. Am J Clin Pathol 122(6):884–893

    CAS  PubMed  Google Scholar 

  98. Iyoda A, Hiroshima K, Toyozaki T, Haga Y, Fujisawa T, Ohwada H (2001) Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology. Cancer 91(11):1992–2000

    CAS  PubMed  Google Scholar 

  99. Hiroshima K, Abe S, Ebihara Y et al (2005) Cytological characteristics of pulmonary large cell neuroendocrine carcinoma. Lung Cancer 48(3):331–337

    PubMed  Google Scholar 

  100. Iyoda A, Baba M, Hiroshima K et al (2004) Imprint cytologic features of pulmonary large cell neuroendocrine carcinoma: comparison with classic large cell carcinoma. Oncol Rep 11(2):285–288

    PubMed  Google Scholar 

  101. Kakinuma H, Mikami T, Iwabuchi K et al (2003) Diagnostic findings of bronchial brush cytology for pulmonary large cell neuroendocrine carcinomas: comparison with poorly differentiated adenocarcinomas, squamous cell carcinomas, and small cell carcinomas. Cancer 99(4):247–254

    PubMed  Google Scholar 

  102. Nicholson SA, Ryan MR (2000) A review of cytologic findings in neuroendocrine carcinomas including carcinoid tumors with histologic correlation. Cancer 90(3):148–161

    CAS  PubMed  Google Scholar 

  103. Wiatrowska BA, Krol J, Zakowski MF (2001) Large-cell neuroendocrine carcinoma of the lung: proposed criteria for cytologic diagnosis. Diagn Cytopathol 24(1):58–64

    CAS  PubMed  Google Scholar 

  104. Yang YJ, Steele CT, Ou XL, Snyder KP, Kohman LJ (2001) Diagnosis of high-grade pulmonary neuroendocrine carcinoma by fine-needle aspiration biopsy: nonsmall-cell or small-cell type? Diagn Cytopathol 25(5):292–300

    CAS  PubMed  Google Scholar 

  105. Jimenez-Heffernan JA, Lopez-Ferrer P, Vicandi B et al (2008) Fine-needle aspiration cytology of large cell neuroendocrine carcinoma of the lung: a cytohistologic correlation study of 11 cases. Cancer 114(3):180–186

    PubMed  Google Scholar 

  106. Sturm N, Lantuejoul S, Laverriere MH et al (2001) Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung. Hum Pathol 32(9):918–925

    CAS  PubMed  Google Scholar 

  107. Jiang SX, Kameya T, Shoji M, Dobashi Y, Shinada J, Yoshimura H (1998) Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases. Am J Surg Pathol 22(5):526–537

    CAS  PubMed  Google Scholar 

  108. Lantuejoul S, Moro D, Michalides RJ, Brambilla C, Brambilla E (1998) Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors. Am J Surg Pathol 22(10):1267–1276

    CAS  PubMed  Google Scholar 

  109. Folpe AL, Gown AM, Lamps LW et al (1999) Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol 12(1):5–8

    CAS  PubMed  Google Scholar 

  110. Travis WD, Gal AA, Colby TV, Klimstra DS, Falk R, Koss MN (1998) Reproducibility of neuroendocrine lung tumor classification. Hum Pathol 29(3):272–279

    CAS  PubMed  Google Scholar 

  111. Ab’ Saber AM, Massoni Neto LM, Bianchi CP et al (2004) Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas. Ann Thorac Surg 77(6):1883–1890

    PubMed  Google Scholar 

  112. Graziano SL, Mazid R, Newman N et al (1989) The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer. J Clin Oncol 7:1398–1406

    CAS  PubMed  Google Scholar 

  113. Howe MC, Chapman A, Kerr K, Dougal M, Anderson H, Hasleton PS (2005) Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy. Histopathology 46(2):195–201

    CAS  PubMed  Google Scholar 

  114. Hiroshima K, Iyoda A, Shibuya K et al (2002) Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung. Ann Thorac Surg 73(6):1732–1735

    PubMed  Google Scholar 

  115. Carnaghi C, Rimassa L, Garassino I, Santoro A (2001) Clinical significance of neuroendocrine phenotype in non-small-cell lung cancer. Ann Oncol 12(Suppl. 2):S119–S123

    PubMed  Google Scholar 

  116. Baldi A, Groger AM, Esposito V, Di Marino MP, Ferrara N, Baldi F (2000) Neuroendocrine differentiation in non-small cell lung carcinomas. In Vivo 14(1):109–114

    CAS  PubMed  Google Scholar 

  117. Abbona G, Papotti M, Viberti L, Macri L, Stella A, Bussolati G (1998) Chromogranin A gene expression in non-small cell lung carcinomas. J Pathol 186(2):151–156

    CAS  PubMed  Google Scholar 

  118. Hage R, Elbers HR, Brutel de la Rivière A, van den Bosch JM (1998) Neural cell adhesion molecule expression: prognosis in 889 patients with resected non-small cell lung cancer. Chest 114(5):1316–1320

    CAS  PubMed  Google Scholar 

  119. Kwa HB, Verheijen MG, Litvinov SV, Dijkman JH, Mooi WJ, van Krieken JH (1996) Prognostic factors in resected non-small cell lung cancer: an immunohistochemical study of 39 cases. Lung Cancer 16(1):35–45

    CAS  PubMed  Google Scholar 

  120. Schleusener JT, Tazelaar HD, Jung SH et al (1996) Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma. Cancer 77:1284–1291

    CAS  PubMed  Google Scholar 

  121. Senderovitz T, Skov BG, Hirsch FR (1995) Neuroendocrine characteristics in malignant lung tumors: implications for diagnosis, treatment, and prognosis. Cancer Treat Res 72:143–154

    CAS  PubMed  Google Scholar 

  122. Linnoila RI, Piantadosi S, Ruckdeschel JC (1994) Impact of neuroendocrine differentiation in non-small cell lung cancer. The LCSG experience. Chest 106:367S–371S

    CAS  PubMed  Google Scholar 

  123. Carles J, Rosell R, Ariza A et al (1993) Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer. Lung Cancer 10:209–219

    CAS  PubMed  Google Scholar 

  124. Pujol JL, Simony J, Demoly P et al (1993) Neural cell adhesion molecule and prognosis of surgically resected lung cancer. Am Rev Respir Dis 148:1071–1075

    CAS  PubMed  Google Scholar 

  125. Skov BG, Sorensen JB, Hirsch FR, Larsson LI, Hansen HH (1991) Prognostic impact of histologic demonstration of chromogranin A and neuron specific enolase in pulmonary adenocarcinoma. Ann Oncol 2:355–360

    CAS  PubMed  Google Scholar 

  126. Sundaresan V, Reeve JG, Stenning S, Stewart S, Bleehen NM (1991) Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours. Br J Cancer 64:333–338

    CAS  PubMed  Google Scholar 

  127. Berendsen HH, de Leij L, Poppema S et al (1989) Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features. J Clin Oncol 7:1614–1620

    CAS  PubMed  Google Scholar 

  128. Ionescu DN, Treaba D, Gilks CB et al (2007) Nonsmall cell lung carcinoma with neuroendocrine differentiation – an entity of no clinical or prognostic significance. Am J Surg Pathol 31(1):26–32

    PubMed  Google Scholar 

  129. Segawa Y, Takata S, Fujii M et al (2009) Immunohistochemical detection of neuroendocrine differentiation in non-small-cell lung cancer and its clinical implications. J Cancer Res Clin Oncol 135(8):1055–1059

    CAS  PubMed  Google Scholar 

  130. Iyoda A, Hiroshima K, Moriya Y et al (2006) Prospective study of adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma. Ann Thorac Surg 82(5):1802–1807

    PubMed  Google Scholar 

  131. Rossi G, Cavazza A, Marchioni A et al (2005) Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and met in large-cell neuroendocrine carcinoma of the lung. J Clin Oncol 23(34):8774–8785

    CAS  PubMed  Google Scholar 

  132. Yamazaki S, Sekine I, Matsuno Y et al (2005) Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy. Lung Cancer 49(2):217–223

    PubMed  Google Scholar 

  133. Filosso PL, Ruffini E, Oliaro A et al (2005) Large-cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighteen cases and the efficacy of adjuvant treatment with octreotide. J Thorac Cardiovasc Surg 129(4):819–824

    CAS  PubMed  Google Scholar 

  134. Doddoli C, Barlesi F, Chetaille B et al (2004) Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery. Ann Thorac Surg 77(4):1168–1172

    PubMed  Google Scholar 

  135. Paci M, Cavazza A, Annessi V et al (2004) Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study. Ann Thorac Surg 77(4):1163–1167

    PubMed  Google Scholar 

  136. Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58(2):71–96

    PubMed  Google Scholar 

  137. Govindan R, Page N, Morgensztern D et al (2006) Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 24(28):4539–4544

    PubMed  Google Scholar 

  138. Krug LM, Kris MG, Rosenzweig K, Travis WD (2008) Cancer of the lung: small cell and other neuroendocrine tumors of the lung. In: DeVita VT, Lawrence TS, Rosenberg SA, Weinberg RA, Depinho RA (eds) DeVita, Hellman and Rosenberg’s cancer, principles and practice of oncology. Wolters Kluwer, Lippincott Williams and Wilkins, Philadelphia, pp 946–971

    Google Scholar 

  139. Quoix E, Fraser R, Wolkove N, Finkelstein H, Kreisman H (1990) Small cell lung cancer presenting as a solitary pulmonary nodule. Cancer 66:577–582

    CAS  PubMed  Google Scholar 

  140. Zelen M (1973) Keynote address on biostatistics and data retrieval. Cancer Chemother Rep 3 4(2):31–42

    CAS  PubMed  Google Scholar 

  141. Shepherd FA, Crowley J, Van HP et al (2007) The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2(12):1067–1077

    PubMed  Google Scholar 

  142. Nicholson SA, Beasley MB, Brambilla E et al (2002) Small Cell Lung Carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol 26(9):1184–1197

    PubMed  Google Scholar 

  143. Vollmer RT (1982) The effect of cell size on the pathologic diagnosis of small and large cell carcinomas of the lung. Cancer 50:1380–1383

    CAS  PubMed  Google Scholar 

  144. Vollmer RT, Ogden L, Crissman JD (1984) Separation of small-cell from non-small-cell lung cancer. The Southeastern Cancer Study Group pathologists’ experience. Arch Pathol Lab Med 108:792–794

    CAS  PubMed  Google Scholar 

  145. Roggli VL, Vollmer RT, Greenberg SD, McGavran MH, Spjut HJ, Yesner R (1985) Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases. Hum Pathol 16:569–579

    CAS  PubMed  Google Scholar 

  146. Hiroshima K, Iyoda A, Shida T et al (2006) Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis. Mod Pathol 19(10):1358–1368

    CAS  PubMed  Google Scholar 

  147. Agoff SN, Lamps LW, Philip AT et al (2000) Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors [In Process Citation]. Mod Pathol 13(3):238–242

    CAS  PubMed  Google Scholar 

  148. Merrill RM, Henson DE, Barnes M (1999) Conditional survival among patients with carcinoma of the lung. Chest 116(3):697–703

    CAS  PubMed  Google Scholar 

  149. Hiroshima K, Iyoda A, Shibuya K et al (2004) Genetic alterations in early-stage pulmonary large cell neuroendocrine carcinoma. Cancer 100(6):1190–1198

    CAS  PubMed  Google Scholar 

  150. Jiang SX, Kameya T, Shinada J, Yoshimura H (1999) The significance of frequent and independent p53 and bcl-2 expression in large-cell neuroendocrine carcinomas of the lung. Mod Pathol 12(4):362–369

    CAS  PubMed  Google Scholar 

  151. Przygodzki RM, Finkelstein SD, Langer JC et al (1996) Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Am J Pathol 148:1531–1541

    CAS  PubMed  Google Scholar 

  152. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49–53

    CAS  PubMed  Google Scholar 

  153. Beasley MB, Lantuejoul S, Abbondanzo S et al (2003) The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung. Hum Pathol 34(2):136–142

    CAS  PubMed  Google Scholar 

  154. Igarashi T, Jiang SX, Kameya T et al (2004) Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors. Mod Pathol 17(10):1259–1267

    CAS  PubMed  Google Scholar 

  155. Kobayashi Y, Tokuchi Y, Hashimoto T et al (2004) Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors. Cancer Sci 95(4):334–341

    CAS  PubMed  Google Scholar 

  156. Pelosi G, Masullo M, Leon ME et al (2004) CD117 immunoreactivity in high-grade neuroendocrine tumors of the lung: a comparative study of 39 large-cell neuroendocrine carcinomas and 27 surgically resected small-cell carcinomas. Virchows Arch 445(5):449–455

    PubMed  Google Scholar 

  157. Araki K, Ishii G, Yokose T et al (2003) Frequent overexpression of the c-kit protein in large cell neuroendocrine carcinoma of the lung. Lung Cancer 40(2):173–180

    PubMed  Google Scholar 

  158. Casali C, Stefani A, Rossi G et al (2004) The prognostic role of c-kit protein expression in resected large cell neuroendocrine carcinoma of the lung. Ann Thorac Surg 77(1):247–252

    PubMed  Google Scholar 

  159. Dong Q, Debelenko LV, Chandrasekharappa SC et al (1997) Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 82(5):1416–1420

    CAS  PubMed  Google Scholar 

  160. Debelenko LV, Brambilla E, Agarwal SK et al (1997) Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 6(13):2285–2290

    CAS  PubMed  Google Scholar 

  161. Debelenko LV, Swalwell JI, Kelley MJ et al (2000) MEN1 gene mutation analysis of high-grade neuroendocrine lung carcinoma. Genes Chromosomes Cancer 28(1):58–65

    CAS  PubMed  Google Scholar 

  162. Lim E, Goldstraw P, Nicholson AG et al (2008) Proceedings of the IASLC international workshop on advances in pulmonary neuroendocrine tumors 2007. J Thorac Oncol 3(10):1194–1201

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10021, USA

    William D. Travis

Authors
  1. William D. Travis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William D. Travis .

Editor information

Editors and Affiliations

  1. Dept. Laboratory Medicine & Pathology, Mayo Clinic, First Street SW 200, Rochester, 55905, U.S.A.

    Ricardo V. Lloyd

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Travis, W.D. (2010). Endocrine Lung. In: Lloyd, R. (eds) Endocrine Pathology:. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1069-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1069-1_19

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1068-4

  • Online ISBN: 978-1-4419-1069-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation